This inventor holds 2 USPTO granted patents. Top assignee: Asta Pharma Aktiengesellschaft. Active years: 1993.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1993
Title: Friedrich Maiterth: Innovator in Antitumor Platinum Complexes
Introduction
Friedrich Maiterth is a notable inventor based in Hagelstadt, Germany. He has made significant contributions to the field of chemistry, particularly in the development of antitumor platinum complexes. With a total of two patents to his name, Maiterth's work is recognized for its potential impact on cancer treatment.
Latest Patents
Maiterth's latest patents include innovative formulations of ethylene-substituted phenylalkylethylenediamine-platinum (II or IV) complexes. These complexes are designed to exhibit antitumor properties and are characterized by a complex chemical structure that allows for various substitutions and modifications. The detailed chemical formulas highlight the versatility and potential efficacy of these compounds in therapeutic applications.
Career Highlights
Throughout his career, Maiterth has focused on the intersection of chemistry and medicine. His work has contributed to advancements in the development of new treatments for cancer, showcasing his commitment to improving patient outcomes through innovative research.
Collaborations
Maiterth has collaborated with esteemed colleagues such as Henri Brunner and Peter Hankofer. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical compounds.
Conclusion
Friedrich Maiterth's contributions to the field of antitumor platinum complexes underscore his role as an influential inventor. His innovative work continues to pave the way for advancements in cancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile